The Worldwide Cell Culture Industry is Expected to Reach $60.2 Billion by 2030: Expansion in the Scope of Cell Culture Technology Drives Growth

DUBLIN, Jan. 20, 2023 /PRNewswire/ -- The "Cell Culture Market Size, Share & Trends Analysis Report by Consumable (Media, Sera, Reagents), by Product (Culture Systems, Centrifuges), by Application, by Region, and Segment Forecasts, 2022-2030" report has been added to  ResearchAndMarkets.com's offering.

The global cell culture market size is expected to reach USD 60.27 billion by 2030, expanding at a CAGR of 11.9% from 2022 to 2030, according to this report.

This can be attributed to the increase in biopharmaceutical production, advancements in vaccine research and development, and increasing focus on genetic engineering applications that rely heavily on cell culture techniques.

Innovations in cell culture workflow automation, such as the commercial development of integrated robotic liquid handling systems, are expected to significantly boost the capabilities of current cell culture technologies. For instance, culturing processes are expected to witness improvements in capacity handling and efficiency, and reproducibility in operations.

Similarly, automation in cell line development technologies is gaining traction with the launch of new platforms. For instance, in October 2021, CYTENA launched C.STATION, a fully automated cell line development platform, for enhancing antibody and gene therapy production. Such product launches are likely to increase the market penetration of cell culture offerings.

Cell culture models play a pivotal role in the development of novel therapeutics for diseases such as diabetes, cancer, and Parkinson's diseases.

With the increasing emphasis on research and development activities exploring therapeutic candidates for such diseases, the demand for customized media for use in preclinical research is expected to drive the market.

Furthermore, demand for serum-free media is likely to witness significant growth due to increasing quality constraints in biopharmaceuticals and the requirement for highly consistent and standardized culturing conditions.

The COVID-19 pandemic has boosted the demand for cell culture products due to the significant role played by culturing technologies in the discovery of novel diagnostic and therapeutic options for the disease. For instance, research applications such as high-throughput COVID-19 drug screening for the identification of potential drug candidates or investigations aimed at understanding the mechanism of viral entry into the host cells are expected to positively affect the market growth.

Furthermore, culturing techniques offer essential tools for the production of viral particles for vaccine development, thereby broadening the growth prospects in this domain.

Cell Culture Market Report Highlights

• By consumable, the media segment accounted for the largest revenue share of over 50.0% in 2021 due to the availability of a variety of serum- and animal component-free and customized media alternatives, which has increased the market penetration for media products
• Based on product, culture systems held the largest revenue share of over 25.0% in 2021. This can be attributed to the technological advancements in automated systems for research & development applications
• The biopharmaceuticals application segment dominated the market in 2021 with a revenue share of over 25.0% due to the involvement of mammalian lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for non-conventional drugs
• North America held the largest revenue share in 2021 due to high research and development investments, the presence of a well-established scientific infrastructure, significant demand for animal component-free media, and other factors
• The Asia Pacific region is estimated to grow at the fastest rate over the forecast period due to the growing healthcare expenditure, rising awareness regarding regenerative therapies, and a large potential for clinical research applications

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Cell Culture Market Variables, Trends & Scope
3.1 Market Trends & Outlook
3.2 Market Segmentation & Scope
3.3 Market Driver Analysis
3.3.1 Expansion in the scope of cell culture technology
3.3.2 Demand for biopharmaceuticals, artificial organs & vaccine production
3.3.3 demand for serum - free, specialty and customized media
3.4 market restraint analysis
3.4.1 Stringent process control
3.4.2 Scalability issues
3.4.3 ethical concern over use of animals
3.5 Swot Analysis, by Factor (political & legal, economic, and technological)
3.6 Porter's Five Forces Analysis
3.7 Covid-19 impact Analysis
3.8 Penetration & Growth Prospect Mapping

Chapter 4 Cell Culture Market - Segment Analysis, by Consumable, 2018 - 2030 (USD Million)
4.1 Cell Culture Market: Consumable Movement Analysis
4.2 media
4.2.1 Media Market Estimates and Forecast, 2018 - 2030 (USD Million)
4.2.2 Minimum Essential Media (MEM)
4.2.2.1 Minimum Essential Media (MEM) market estimates and forecast, 2018 - 2030 (USD Million)
4.2.3 RPMI 1640 media
4.2.3.1 RPMI 1640 media market estimates and forecast, 2018 - 2030 (USD Million)
4.2.4 DMEM / f-12 media
4.2.4.1 DMEM / f-12 media market estimates and forecast, 2018 - 2030 (USD Million)
4.2.5 F-10 serum-free media
4.2.5.1 F-10 serum-free media market estimates and forecast, 2018 - 2030 (USD Million)
4.2.6 Basal Medium Eagle (BME) media
4.2.6.1 Basal Medium Eagle (BME) media market estimates and forecast, 2018 - 2030 (USD Million)
4.2.7 Insect media
4.2.7.1 Insect media market estimates and forecast, 2018 - 2030 (USD Million)
4.2.8 Others
4.2.8.1 Other media market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Sera
4.3.1 Sera market estimates and forecast, 2018 - 2030 (USD Million)
4.3.2 Fetal Bovine Serum
4.3.2.1 Fetal Bovine Serum market estimates and forecast, 2018 - 2030 (USD Million)
4.3.3 others
4.3.3.1 Other Sera market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Reagents
4.4.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
4.4.2 Albumin
4.4.2.1 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
4.4.3 Others
4.4.3.1 Other reagents market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Cell Culture Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
5.1 Cell culture market: product movement analysis
5.2 culture systems
5.2.1 Culture systems market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Incubators
5.3.1 Incubators market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Centrifuges
5.4.1 Centrifuges market estimates and forecast, 2018 - 2030 (USD Million)
5.5 cryostorage equipment
5.5.1 Cryostorage equipment market estimates and forecast, 2018 - 2030 (USD Million)
5.6 Biosafety equipment
5.6.1 Biosafety equipment market estimates and forecast, 2018 - 2030 (USD Million)
5.7 Pipetting instruments
5.7.1 Pipetting instruments market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Cell Culture Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
6.1 Cell culture market: application movement analysis
6.2 Biopharmaceuticals
6.2.1 Biopharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Tissue culture &engineering
6.3.1 Tissue culture & engineering market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Vaccine production
6.4.1 Vaccine production market estimates and forecast, 2018 - 2030 (USD Million)
6.5 drug development
6.5.1 Drug development market estimates and forecast, 2018 - 2030 (USD Million)
6.6 Gene therapy
6.6.1 Gene therapy market estimates and forecast, 2018 - 2030 (USD Million)
6.7 toxicity testing
6.7.1 Toxicity testing market estimates and forecast, 2018 - 2030 (USD Million)
6.8 Cancer research
6.8.1 Cancer research market estimates and forecast, 2018 - 2030 (USD Million)
6.9 other
6.9.1 Other market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Cell Culture Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

Chapter 8 Competitive Analysis
8.1 Strategy Framework
8.2 Company/Competition Categorization
8.3 Company Profiles
8.3.1. BIO-RAD LABORATORIES, INC.
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. THERMO FISHER SCIENTIFIC, INC.
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. BECTON, DICKINSON & COMPANY
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. MERCK KGAA
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. SARTORIUS AG
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. VWR INTERNATIONAL, LLC
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. EPPENDORF SE
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. PROMOCELL GMBH
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. BIO-TECHNE CORPORATION
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. BIOSPHERIX, LTD.
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/qv79xy

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected] 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets